Literature DB >> 35239932

Orthostatic changes in blood pressure and survival in elderly cardiopaths.

Laura Mariana de Siqueira Mendonça Chaves1, João Victor Batista Cabral2, Maria Mariana Barros Melo da Silveira2, Márcia Cristina Amélia da Silva1, Analú Corrêa de Souza1, Dinaldo Cavalcanti de Oliveira2, Dário Celestino Sobral Filho1, Ulisses Ramos Montarroyos1.   

Abstract

OBJECTIVE: The objective of this study was to analyze the association between orthostatic changes in blood pressure and mortality in elderly cardiopath patients.
METHODS: A cohort of 455 elderly cardiopath patients, monitored at a referral outpatient cardiology clinic in Pernambuco, Brazil, from October 2015 to July 2018. The exposure groups were formed according to their orthostatic changes in blood pressure following the requirements of the Brazilian Guidelines for Hypertension.
RESULTS: Orthostatic hypotension was present in 46 patients (10.1%), 91 had orthostatic hypertension (20%), and 318 had no orthostatic alterations (69.9%). There were 52 deaths during follow-up. The results demonstrated that there was no statistically significant association between orthostatic hypotension and overall mortality (HR 1.30; 95%CI 0.53-3.14; p=0.567) nor between orthostatic hypertension and overall mortality (HR 0.95; 95%CI 0.65-1.39; p=0.34). Survival in relation to the exposure groups presented no statistically significant difference (p=0.504).
CONCLUSION: There was a low frequency of orthostatic hypotension and a mild high frequency of orthostatic hypertension when compared with previous studies, and no association was observed with overall mortality or with the survival time of elderly patients with heart disease.

Entities:  

Mesh:

Year:  2022        PMID: 35239932     DOI: 10.1590/1806-9282.20210199

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.712


  1 in total

1.  Comment on "Orthostatic changes in blood pressure and survival in elderly cardiopaths".

Authors:  Ming Zhao
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-06-24       Impact factor: 1.712

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.